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ABSTRACT
Objective: The SMART ED study was a randomized, controlled trial of 3 brief
interventions in ER settings targeting high-risk substance use. Findings in the main study
indicated that there was no difference in outcomes for groups receiving minimal, rather
than more extensive, behavioral interventions. This secondary analysis investigated the
quality of (MI) sessions in the SMART ED study to examine the hypothesis that better
quality of MI would be associated with improved client outcomes.
Method: The Motivational Interviewing Treatment Integrity Code (MITI 3.0) was
used to evaluate 388 sessions, yielding indicators of MI Quality including Overall Spirit
(MI Spirit), Reflection to Question (R:Q), Percent Open Questions (%OQ), MI Adherent
(MIA) and MI Non-Adherent (MINA) behaviors. These quality indicators were used to
predict client outcomes, measured as self-reported days of primary drug use, days with
any drug use, and days of heavy drinking.
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Results: Fewer than half (49%) of sessions met minimal criteria for MI quality

using the MITI 3.0. Only 7% of sessions met the criteria for advanced MI practice.
None of these indicators were associated with substance use outcomes.
Conclusions: These findings raise the possibility that negative trials of MI may be
accounted for by poor adherence to the method, rather than lack of efficacy.
Recommendations for quality monitoring and standards for future studies using
behavioral treatments are discussed.
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Chapter 1
Introduction
Motivational Interviewing and the Importance of Treatment Fidelity
Motivational Interviewing (MI) is a therapeutic method aimed to motivate clients
towards health behavior change by exploring and resolving ambivalence (Burke et al.,
2003; Miller & Rollnick, 2012). The modality incorporates both a relational component
rooted in client-centered humanistic therapy (Rogers, 1951) and a technical component
designed to facilitate client language in favor of change (Miller & Rose, 2009). Since the
conception of MI in 1983, there has been extensive exploration into its efficacy for a
variety of health behaviors including: alcohol and drug use, weight loss, diabetes
management, adherence to medical treatments, sexual risk behaviors, gambling, and
parenting behaviors (Armstrong et al., 2011; Harding et al., 2001; Parsons et al., 2005;
Vasilaki, Hosier, & Cox, 2006; Webb, DeRubeis, & Barber, 2010) across a variety of
settings including: medicine, counseling, and corrections (Lundahl et al., 2013;
McMurran, 2009; Hettema, Steele, & Miller, 2005; VanBuskirk, & Wetherell, 2014).
Recent MI meta-analyses find that 75% of participants show improvement in outcomes
with small to moderate effect sizes compared to no-treatment conditions (Burke et al.,
2003; Hettema, Steele, & Miller, 2005; Lundahl et al., 2013; Rubak et al., 2005;
Valislaki, Hoiser, & Cox, 2006;). fMI improvements relative to other treatment
modalities are mixed, with some meta-analyses finding equivalent outcomes (Hettema,
Steele, & Miller, 2005; Lundahl et al., 2013) and others finding significant positive
results with only small effect sizes (Rubak et al., 2005).
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These modest effects may be accounted for, in part, by treatment fidelity. Fidelity
establishes that the intervention given was the one intended (McLeod, Southam-Gerow,
& Weisz 2009; Perepletchikova & Kazdin, 2005). It also allows potential differences in
treatments to be observed if they exist. Further, measuring adherence offers researchers
the opportunity to maintain the distinct elements of the intervention. This is important
because one common issue in psychotherapy trials is drift: treatments wander from the
what was originally planned (Beidas & Kendall, 2010; Chorpita & Nakamura, 2004;
Damschroder & Hagedorn, 2011). Lack of attention to quality leads to little confidence in
the interpretation of results for examinations of MI efficacy.
Fidelity problems are particularly critical for investigations of MI for a few
reasons. First, a clear imbalance exists in quality of MI research. Some studies have been
methodologically less rigorous than others with the gold standard being controlled
clinical trials. (Burke et al., 2003; Miller & Moyers, 2015). Second, the training methods,
supervision, and monitoring of therapists across randomized controlled trials (RCTs)
greatly varies (Madson, et al. 2005). Third, there are concerns that some explorations
have implemented MI in a way that violates its spirit (Moyers, Martin, Catley, Harris, &
Ahluwalia, 2003; Rollnick & Miller, 1995).
Moreover, MI in its pure form is rarely used, even in pivotal projects such as
MATCH. A vast majority of studies combine the method with other components and
refer to this conglomerate as “MI” (Acosta, Haller, & Ingersoll, 2010; Madson et al.,
2005; Miller & Sanchez, 1994; Miller & Rollnick, 2012; Kadden et al., 1998; COMBINE
Study Research Group, 2003). Examples of this additive treatment include MI plus: 1)
feedback (known as MET), 2) another type of treatment (such as Cognitive Behavioral
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Therapy), and 3) psychoeducation (Miller, 1995; Parsons et al., 2005; D’Amico et al.,
2015). This body of evidence, as it stands now, cannot elucidate whether these studies
truly are engaging in the modality they claim. Furthermore, is it the MI, the additions, or
the combination that are accounting for the current findings?
In addition to muddying the waters of research findings, lack of treatment fidelity
measurement can be a hindrance to the clinical training and practice of MI. Treatment
competence is a powerful clinical tool. It can be used to provide feedback which can help
practitioners acquire new skills or continue to refine and improve techniques after
learning them. Monitoring treatment quality can also help practitioners to better
understand how their application of MI may change across different types of patient
characteristics and populations. More importantly, MI integrity ensures best care and
maximum impact of the treatment for clients (Burnam, Hepner, & Miranda 2009).
Measuring Treatment Fidelity in MI Research
Given the ways that a lack of fidelity can confuse the interpretation of RCTs and
impact client outcomes, clinical scientists advocate for psychotherapy studies to
consistently measure treatment quality (Southam-Gerow & McLeod, 2013;
Perepletchikova & Kazdin, 2005). Despite its importance, most modalities have yet to
create ways to measure intervention accuracy and only 3.5% of all treatment studies
report adherence (Perepletchikova & Kazdin, 2005; Perepletchikova, 2011).
MI has an advantage in that many assessments have already been generated and
evaluated. A recent systematic review found 5 measures that ranged in psychometric
quality (Madson and Campbell, 2006). Although several excellent systems exist, the most
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widely used is the Motivational Interviewing Treatment Integrity Code (MITI; Moyers et
al., 2005; Moyers et al., 2016).
The MITI quantifies practitioners’ ability to adhere to the theoretically proposed
components of MI: the relational elements and technical skills. The global scores
incorporate an overall impression of a therapeutic interaction, and are rated on a 5-pointLikert scale. On the other hand, the behavior counts involve a tally of specific verbal
events across a session. The instrument also provides summary scores that are widely
used in clinical settings to determine competency, but have yet to be empirically
validated (Moyers et al., 2005). For a full description of all of these elements, see Table
1.
The MITI 3.0 has many strengths. The instrument is psychometrically sound
having shown in multiple samples to have good reliability, validity, and sensitivity
(Moyers et al., 2003; Moyers et al. 2005; Forsberg et al. 2007). Further, it is one of the
few MI fidelity tools that is multimodal (global scores and behavior counts) and sets
proficiency benchmarks, see Table 2 (Moyers et al., 2005). This measure is free of
charge, has open source access, and is available at the following website:
https://casaa.unm.edu/code/miti.html.
Surprisingly, given the availability and strengths of the MITI, treatment quality is
variably reported in studies of MI efficacy (Handmaker, Miller, & Manicke, 1999;
Madson & Campbell, 2006). As with other treatment types, MI researchers have
suggested the need for future studies to measure and report treatment quality in order
better understand the method’s efficacy (Miller, 2001; Madson & Campbell, 2006).
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Mixed findings in MI research can potentially be clarified by accounting for lack
of treatment fidelity. One strategy to achieve this aim is to reanalyze data from existing
studies that both reported quality and found no effect of MI on client outcome. In this
study, a RCT was selected to conduct just such a secondary analysis.
The Original Study: Background, Purpose, and Findings
In order to ensure anonymity of the therapists, the study name and exact setting
will be kept confidential. The parent project was conducted in a medical setting directly
following urgent medical visits. The purpose was to investigate the effect of brief MI and
referral for alcohol and drug users. The study compared the efficacy of three distinct
treatment conditions: 1) minimal screening only (Screening), 2) screening, assessment,
and referral to treatment (Assessment), and 3) screening, assessment, and referral plus
brief MI and two follow-up MI booster sessions (MI). The authors hypothesized that the
MI condition would decrease later alcohol and drug use as compared to the control
conditions. Alcohol and drug use outcomes were: 1) self-reported days of primary drug
use, 2) days with any drug use, and 3) days of heavy drinking, and were measured at 3, 6,
and 12-months post treatment. The study yielded no significant differences between
treatment conditions for alcohol and drug use across any follow-up point. Treatment
fidelity was measured for the MI condition, using the MITI 3.0, but was only used to give
clinical feedback to practitioners and was not reported in publications.
The Current Study
The purpose of this secondary analysis was to re-examine the MI treatment
condition based on quality, as measured by the MITI benchmarks, to see if a significant
treatment effect could be found. Given there has been debate over the meaning and use of
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the terms “proficiency” and “competency” (Perepletchikova & Kazdin, 2005) this study
will henceforth use the terms Beginner and Full-Strength MI, respectively. Our approach
was multi-fold.
Aim 1. The first aim was to reanalyze the data, following the same analysis
strategy as the original study, but using treatment quality as the grouping variable. To
accomplish this aim, the baseline sessions of the MI treatment group were divided by
quality, following the MITI competency benchmarks: Beginner versus Full-Strength.
After this split, the differences between the two new MI conditions (Beginner and FullStrength) on client outcomes (self-reported days of primary drug use, days with any drug
use, and days of heavy drinking), were compared. Follow-up analyses investigated
differences across all four treatment conditions: a) screening, b) assessment, c) Beginner
MI and d) Full-Strength MI, using the same client outcome variables.
Hypothesis Aim 1. We expected that there would be a significant difference
between MI groups, with the Full-Strength MI condition having better client outcomes as
compared to the three other conditions (Beginner MI, Assessment, and Screening).
Aim 2. The second aim was to investigate if aspects of the MITI were associated
with client outcome. In order to achieve this aim, two approaches were utilized: a datadriven and a theory-driven approach.
The data-driven approach determined the underlying latent variables for the MITI
3.0 and the factor loadings. Factor scores were computed for each therapy session. Then a
regression was used to determine whether these factor scores accounted for a significant
proportion of the variance in client outcomes.
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The theory-driven approach examined whether particular constructs, important to
MI theory, accounted for a significant proportion of the variance in client outcome. Given
their theoretical significance and common clinical use, the MITI 3.0 summary scores (the
average of the global scores, reflection to question ratio, percent open questions, percent
complex reflections, and percent MI-Adherent behaviors) were investigated. We tested
whether these variables accounted for a significant proportion of variance in client
outcomes using regression analyses.
Hypothesis Aim 2. For the data-driven approach, we expected an underlying
factor(s) would account for a significant proportion of the variance in client outcomes.
For the theory-driven approach, we expected that all variables (an average of the global
scores, reflection to question ratio, percent open questions, percent complex reflections,
and percent MI-Adherent behaviors) would account for a significant proportion of the
variance in client outcomes.
Aim 3. The third aim of this study was to ensure that the dose of MI was not
conflating the competency findings in Aim 1. This was necessary as MITI scores used in
the previous aims were only evaluated at baseline although many participants received
two follow-up MI booster sessions. To accomplish this aim, we investigated whether
dose, as measured by the number of sessions a participant received, was significantly
associated with client outcome using linear regression.
Hypothesis for Aim 3. We expected that the dose of MI, as measured by the
number of sessions a participant received, would not be significantly associated with
client outcome.

8
Aim 4. The final aim of this study was to investigate how much variance in client
outcomes was accounted for by the individual therapist.
Hypothesis for Aim 4. We expected that the particular therapist a client received
would be associated with client outcome.
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Chapter 2
Methods
Participants
Data were drawn from participants who were seeking medical treatment in six
different locations across the United States. All were 18 or older, did not have significant
impairment of cognition or judgment (i.e., delirium, traumatic brain injury or
intoxication), spoke English, provided informed consent, had access to a telephone,
indicated moderate to severe drug use problems, and reported at least 1 day of drug use in
the 30 days prior to screening. Participants were compensated up to $275 for completing
the study. For the current project, all participants in the three treatment conditions were
included (N=1246) with the exception of 34 participants from the MI condition who were
missing audio recordings.
Measures
All participants received a baseline assessment before randomization to treatment
groups. To assess for alcohol and drug consumption, the following measures were
included the: 1) Thirty-day timeline follow-back (TLFB) interview (Sobell & Sobell,
1992) and 2) NIDA-Modified version (NMASSIST) of the WHO ASSIST (Humeniuk,
Ali, & Babor, 2008). Substance use related problems were quantified by the following: 1)
Drug Abuse Screening Test-10 (DAST-10; Skinner, 1982) with scores indicating drug
problem level (0= none, 1-2= Low, 3-5= Moderate, 6-8= Substantial, 9-10= Severe), and
2) Alcohol Use Disorders Identification Test (AUDIT-C; Bush et al., 1998) with scores
indicating hazardous drinking (men scoring 4 or more and women scoring three or more).
The follow-up measures (self-reported days of primary drug use, days with any drug use,
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and days of heavy drinking) were analyzed at three time points: 3, 6, and 12-months posttreatment as measured by the TLFB interview. This secondary analysis used the same
outcome measures as the original study for consistency in comparing results. However,
only outcomes at one time point, three months, will be investigated in order to reduce the
total number of analyses. This reduction both increased power and decreased inflation
bias (Head et al., 2015).
Interventions. Participants in the original study were randomized to one of three
groups: Screening, Assessment, and MI. All interventions (minus the MI booster
sessions) were delivered around each participant’s urgent medical visit.
a) Screening. Participants were given an informational pamphlet about drug use
and its consequences written by the National Institute on Drug Abuse.
b) Assessment. Participants received the same pamphlet as in the screening group.
Additionally, participants were given scripted feedback and referral if warranted.
Feedback included personalized information aimed at warning participants about the
consequences of their high-risk substance use. Referral included a standardized list of
local treatment agencies.
c) MI. Participants received the same pamphlet, scripted feedback, and referral as
in the Assessment condition. Furthermore, the participants received a 30-minute manualguided MI session. The intervention consisted of a personalized feedback report (which
included quantity/frequency of use, monetary consequences, risk factors for dependence,
and normative feedback) and the development of a change plan (which included a
discussion about hypothetical or actual change and developing a plan for change, if
clinically appropriate).
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Between seven days and one month after the initial session, participants received
two twenty-minute follow-up MI booster phone calls. These check-ins included a
discussion aimed at revising the participant’s change plan, reinforcing and supporting
change efforts, and exploring barriers to treatment. Due to attrition, less than half of the
participants received the follow-up booster sessions.
Interventionists. Forty-two research staff, who did not work at the medical center
and had no prior clinical experience, were hired to administer the interventions. To
control for potential therapist effects all interventionists administered all three treatment
conditions.
Training of the therapists included a two-day MI workshop (including lecture,
role play and practice), an additional two-day study-specific training (unspecified), and
feedback from two practice sessions for which the study supervisor (an expert in MI)
measured treatment fidelity. Throughout the study, interventionists had regular
supervision which included MITI 3 coding of one of their recent session recordings.
Fidelity Measure: MITI 3.0. The MITI 3.0 was used to evaluate all baseline MI
sessions by the lead supervisor. Definitions of the global scores, behavior counts, and
summary scores for this measure are found in Table 1. Competency was defined by the
following MITI 3.0 guidelines, see Table 2.
Sessions and Coders. All of the MI intervention sessions from the parent project
(N=388) were included in the current secondary analysis. Three raters were trained in the
MITI 3.0. Coders were deemed competent to begin coding data for the parent study after
receiving good to excellent reliability on all items when compared to an expert coder.
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Weekly coding meetings were held in order to resolve discrepancies and to prevent coder
drift.
Inter-rater Reliability (IRR). A random twenty percent of the sessions were
double coded by an expert rater and used to estimate IRR. Following recent
recommendations (Hallgren, 2012). IRR was assessed with 2-way mixed effects, absolute
agreement, and single measures intraclass correlations (ICC) for each individual item.
The conventional benchmarks for ICCs are as follows: 0.00–0.40 = poor, 0.40–
0.59 = fair, 0.60–0.74 = good, and 0.75–1.00 = excellent (Cicchetti & Sparrow, 1981).
All global and behavior count scores were in the fair to excellent range.
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Chapter 3
Results
Descriptive Statistics
Participants were 70% male with a mean age of 36 years. The ethnicity of the
sample included: 50% White, 20% African American, 28% Hispanic, and 2% other. The
participants’ drug of choice included: 45% Cannabis, 28% Cocaine, 18% Street Opioids,
5% Prescription Opioids, and 4% Methamphetamine. The average score on the DAST-10
was 5.77 (SD = 2.28) indicating a substantial level of drug related problems and the range
was 3-10 indicating moderate to severe problems. The average of the AUDIT-C was 5.43
(3.79) indicating hazardous drinking. Baseline averages for the three outcome measures
were: 1) days of primary drug use (M=15.88, SD=8.70), 2) days of heavy drinking
(M=4.06, SD=6.75), and 3) days of any drug use (M=17.52, SD=8.42).
Aim 1: Treatment Group Comparisons after Categorizing by MI Quality
1.1: Division of the MI Treatment Group. Baseline MI sessions (N=388) were
divided into: Beginner and Full-Strength using the MITI 3.0 competency standards
(Table 2). Descriptive statistics of each of the MITI summary scores for this sample are
summarized in Table 3.
For participants in the parent study MI condition, 51.8% did not meet minimal
standards, 41.5% met the threshold for Beginner MI, and 6.7% met the threshold for Full
Strength MI (Figure 1). Descriptive statistics showing the percentage of intervention
sessions that met each of five MI fidelity criteria are reported in Table 4. The range and
mean of clinician scores for each of the MITI criteria are visually depicted via boxplots in
Figures 2-5.
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To compare the Passable and non-Passable MI conditions with respect to the
outcome variables, three ANOVAs were computed using a linear mixed model,
controlling for treatment site as a fixed effect and baseline use as a covariate. No
significant differences between MI groups for days of primary drug use (F(1, 12) =
97.148, p = .000), days of heavy drinking (F(1, 12) = 125.502, p = .000), and days of any
drug use (F(1, 12) = 77.836, p = .000) existed although there were significant differences
in baseline use. The effect sizes, partial eta squared, were .230, .278, .193, respectively.
1.2: Comparing Passable vs Not-Passable MI on Major Study Outcomes.
The distribution of the three outcome variables were examined for skewness and
kurtosis. They were zero-inflated, but otherwise had normal distribution. Following
recent guidelines for zero-inflated data, no transformations were used because less than
20% of each outcome variable was zeros (Hallgren & Witkiewitz, 2014).
T-tests were conducted to examine if the treatment groups differed in baseline
use. There were no significant differences between the Passable MI condition and NotPassable MI condition for baseline days of primary drug use (t(381) = -.394, p= .239),
days of heavy drinking (t(381) = .139, p = .551), and days of any drug use (t(381) = .097,
p = .233). Additionally there were no significant differences between the two MI groups
and the assessment condition for baseline use on all three variables respectively (t(812) =
-1.759, p= .283; t(812) = .876, p = .368; t(812) = -2.792, p = .922). The screening
condition did not collect these variables and therefore they could not be included. Despite
the absence of significant differences, analyses included baseline use as a covariate
because it has been found to independently predict follow-up use.

15
To compare the Passable and non-Passable MI conditions with respect to the
outcome variables, three ANOVAs were computed using a linear mixed model,
controlling for treatment site as a fixed effect and baseline use as a covariate. No
significant differences between MI groups for days of primary drug use (F(1, 12) =
97.148, p = .000), days of heavy drinking (F(1, 12) = 125.502, p = .000), and days of any
drug use (F(1, 12) = 77.836, p = .000) were found although there were significant
differences in baseline use between groups. The effect sizes, partial eta squared, were
.230, .278, .193, respectively.
1.3: Comparing Passable MI to the Screening and Assessment Conditions.
The original study analysis was replicated using a mixed linear model with
treatment group (Passable MI, Screening, Assessment), and treatment site as fixed factors
and baseline use as a covariate. No significant differences were found between the three
treatment groups for days of primary drug use (F(1, 12) = 133.656, p = .000), days of
heavy drinking (F(1, 12) = 133.555, p = .000), and days of any drug use (F(1, 12) =
117.781, p = .000) although the groups significantly differed in regards to baseline use.
The effect sizes, partial eta squared, were .130, .130, .117, respectively.
The screening group’s baseline use was estimated from an average of the two
other conditions (MI and Assessment) for this analysis because this data was not
collected.
1.4: Comparing Beginner to the Advanced MI.
To compare the Beginner and Advanced MI conditions with respect to the
outcome variables, three ANOVAs were computed using a linear mixed model,
controlling for treatment site as a fixed effect and baseline use as a covariate. No
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significant differences between MI groups for days of primary drug use (F(1, 6) =
99.609, p = .000), days of heavy drinking (F(1, 6) = 131.491, p = .000), and days of any
drug use (F(1, 6) = 78..958, p = .000) were found although there were significant
differences in baseline use between groups. The effect sizes, partial eta squared, were
.239, .281, .190, respectively.
Aim 2: Data Driven and Theory Driven Analyses
2.1: Exploratory Factor Analysis (EFA). An exploratory factor analysis was
conducted using Principal Axis Factoring and Orthogonal Varimax Rotation to derive
estimates of underlying factors within the MITI 3.0. An examination of the Kaiser-Meyer
Olkin Test for sampling adequacy suggested that the data were factorable. The Bartlett’s
Test of Sphericity showed patterned relationships for the individual items of the measure.
Three factors had eigenvalues over 1, and were retained. They explained 65.67% of the
variance. Table 5 shows the factor loadings after rotation using a significant factor
criterion of 0.4.
Seven items: all five global scores (Collaboration, Autonomy Support, Empathy,
Evocation, and Direction) and Complex Reflections loaded onto a first factor. This was
labelled “MI Spirit” as the included components mostly relate to the relational aspects of
the method. The MITI heavily relies on Complex Reflections in the operationalized
definition of Empathy so it follows that these scores were included together.
Six items: MI-Adherent and MI-Non-Adherent, Closed Questions, Simple and
Complex Reflections, Giving Information, all behavior count scores, loaded onto a
second factor. This was labeled “Behavior Counts” because these components were all
measured as tally scores and don’t otherwise relate to each other theoretically.
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Three items (Evocation, Direction, and Open Questions) loaded onto the third
factor. This was labelled “Evocation” because these components relate to the ability to
move the client towards change in a collaborative way.
Factor scores were then calculated.
2.2: Data-Driven Regressions. Three regression analyses were conducted for the
MI group with factor scores as predictor variables, baseline use as a covariate, and the
three outcomes as the dependent variables. None of the factor scores were found to
significantly affect any of the three outcomes and the only significant predictor was
baseline use [F(1, 12) = 94.007, p = .000; F(1, 12) = 140.576, p = .000; F(1, 12) =
76.960, p = .000].
2.3: Theory Driven Regressions. Three stepwise multiple regressions were
conducted using only the Passable MI group. Predictor variables in these models were an
average of the global scores, reflection to question ratio, percent open questions, percent
complex reflections, and percent MI-Adherent. Baseline substance use was a covariate.
None of the predictor variables were found to significantly affect any of the three
outcomes and the only significant predictor was baseline use [F(1, 12) = 57.397, p =
.000; F(1, 12) = 66.900, p = .000; F(1, 12) = 41.667, p = .000].
Aim 3: Dose
Linear regressions, using only the Passable MI group, with dose, as measured by
the number of sessions (one, two, or three) a participant received as a predictor variable,
with baseline use as a covariate, and each of the three-month outcomes as the dependent
variables were computed. Dose was not significantly related to three-month days of
primary drug use, days of heavy drinking, or days of any drug use, although baseline use
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was significant for each of the models [F(1, 12) = 57.397, p = .000; F(1, 12) = 66.900, p
= .000; F(1, 12) = 41.667, p = .000].
Aim 4: Therapist Effects: The proportion of outcomes accounted for by therapist.
Data were analyzed using hierarchical linear modeling to assess the proportion of
days of primary drug use, days of heavy drinking, or days of any drug use at 3-month
post treatment that were accounted for by individual interventionist. We used an
unconditional two-level model with clients nested within therapists. We found that 2.2%
of the variance in days of heavy drinking, 1.17% of days of any drug use, and 0.004% of
days of primary drug of choice was explained by the therapist.
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Chapter 4
Discussion
One clear take-away from these data is that most participants in the parent study
did not receive the intended intervention. The majority of therapists did not meet
minimum standards for MI competency as defined by the MITI. Additionally, of those
that did, they only met beginner not advanced standards.
Given so few sessions met MI quality, it is helpful to discuss how clinicians
excelled and fell short. The clinicians were successful in many ways: they consistently
met the bar for global ratings, such as empathy and partnership, the number of complex
as opposed to simple reflections, and behaviors consistent with MI. In contrast, clinicians
rarely met two criteria to be considered proficient in MI: 1) asking more open than closed
questions and 2) making more reflections than questions. It may be that the latter two
skills are harder to learn for beginning clinicians. This study shines light on particular
abilities that may warrant increased attention for training therapists in both research and
clinical work.
In some ways, the inability of these clinicians to meet MITI thresholds, is not
surprising. It is possible that these interventionists may not have received sufficient
training to learn the method or to become advanced in it. Although their training included
a MI and study-specific workshop (both two days in length), as well as personal feedback
from two practice sessions, this may haven fall short. In one seminal randomized
controlled trial of methods of training MI, the Evaluating Methods for Motivational
Enhancement Education (EMMEE) study, a two-day training was not sufficient to allow
therapists to acquire proficiency one year later (Miller et al., 2004). Rather the whole
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training package (i.e. a two-day workshop, two personal feedback reports on MI
performance, and six individual coaching) was associated with better skill acquisition and
more changes in client language (more change talk and less sustain talk) than any of these
constituent parts alone. The current study included less coaching and feedback over time.
This amount of continued practice and instruction may have been insufficient to obtain
adeptness in the method. The current study further suggests, just like the EMMEE study,
that individualized attention over time is helpful to gain expertise. No one presumes a
novice pianist can take a two-day workshop and then be able to play a masterpiece, yet
this was expected of these novice clinicians learning a complex therapeutic method. This
phenomenon is not exclusive to learning a new therapy modality, but relevant to
acquiring any ability. Evidence of this concept has been supported in the task
performance and learning literature with a meta-analysis indicating spaced practice is
superior to massed practice (Donovan & Radosevich, 1999). Our findings highlight the
importance of training over time for acquiring therapeutic skill.
Another reason these clinicians may not have met acceptable standards of MI
practice is that these standards are unrealistic. MITI summary scores have been routinely
hard to achieve in large scale MI training studies. Despite the 85% proficiency rate
attained in the EMMEE trial, others have been unable to reach such a high benchmark. In
three such studies, this rate ranged from 4.3% to 36% (Baer et al., 2004; Moyers et al.
2008; Tollison et al., 2008). Moreover, just like our secondary analysis, clinicians were
unable to meet two specific criteria: 1) asking more open than closed questions and 2)
making more reflections than questions.
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In fact, only 16% or fewer interventionists in these training trials met competency
on these two indices. This lends further standing to our findings, which suggest these
specific indicators may be impractical.
Despite this level of training, less experienced clinicians (as in the current
investigation) may present a particular challenge. For example, in the Moyers et al.
(2008) training study, the clinicians had less education and fewer years of counseling
experience than the EMMEE trial and had a proficiency rate that ranged from 4.3%10.5%, depending on training enrichments. They still had on average 11 years of
counseling involvement, while therapists in our study had no clinical experience at all. If
current MITI criteria are difficult to achieve with more seasoned clinicians, it may be
impractical to expect as much of novices with no experience. This presents a dilemma for
RCTs: to hire more experienced, more expensive clinicians or to hire less experienced,
cheaper clinicians. A common way to save money in the short run is to hire beginners,
but in the long run this may be costlier if time and money is not spent to train them to
competence. Our findings lead further support to the recommendations set forth by other
psychotherapy trials which suggest providing high quality training over time, continued
monitoring of clinicians throughout a trial, and dismissal of therapists that do not meet
standards (Miller, 2001; Perepletchikova & Kazdin, 2005).
Exploring Quality of MI as Related to Client Outcomes
An over-arching postulation made during this secondary analysis was that the
quality of the intervention would predict client substance use outcome, but we found no
support for this, despite employing multiple strategies for analyses.
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Theoretically Driven Method. Our hypothesis was not supported; none of the
MITI 3.0 summary scores (the averages of the global scores, R:Q, %OQ, %CR, and
%MIA) were associated with better outcomes despite the level of clinician skill. This is
contrary to a substantial body of research that suggests one proposed active ingredient of
MI is change talk, or client language for change (Miller & Rose, 2009; Vader et al., 2010;
Amrhein et al., 2003). Specifically, several studies suggest change talk is associated with
better client outcomes and that this relationship is mediated by therapists’ in-session
behavior (Aharonovich et al., 2008; Baer et al., 2008; Hodgins, Ching, & McEwan,
2009).
The clinician summary variables we explored have been consistently shown in the
literature to be associated with client change language in MI sessions. For example,
global scores are positively associated with alliance and engagement as well as higher
levels of client change talk (Boardman, Catley, Grobe, Little, Ahluwalia, 2006). Further,
MI-Adherent behaviors are associated with both more client language for change in
session (Gaume et al, 2010; Glynn & Moyers, 2010;). Given this array of evidence, our
inability to find any aspects of the MITI associated with client outcome should be taken
with a grain of salt.
It is possible that we were unable to detect these associations because of the
restricted range of our data. Future studies examining similar questions might aim for a
more diverse sample, particularly ones that meet adherence. It is also plausible that the
fidelity measurement tool itself needs refinement. A weakness of the current MITI
standards is that they are derived from expert opinion. Additionally, the MITI was crafted
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for differentiating other modalities from MI and for recognizing beginner level MI, so it
is possible the instrument is not as suitable for discriminating novices from experts.
Empirically Driven Method. The EFA yielded non-intuitive results which did
not predict client outcomes. The factors that emerged seem to have clustered together due
to similarities in the method of measurement rather than similarities in their constructs.
This seems likely because the first factor included predominantly items measured by a
Likert-scale and the second factor included only items measured by tally scores. As well,
the original MITI was derived using an EFA of a more in-depth measure, the
Motivational Interviewing Skill Code (Moyers et al., 2005), so conducting this analysis
may not have been warranted. Something already in its simplest form cannot be further
simplified.
Dose
The number of MI sessions each participant received (one, two, or three) was not
associated with outcome. This finding seems intuitive as there is no reason to expect dose
to be associated with better outcomes when participants did not receive the intended
intervention.
Therapist Effects
The final hypothesis was that the therapist a client received would significantly
impact their drinking and drug use. We found that therapists accounted for 2% or less of
the variance in participant outcomes despite being rated well on global ratings such as
partnership and empathy. This finding is unlike other recent substance abuse research
where therapist effects have been more substantial (Miller and Moyers, 2015). In three
such studies, these effects ranged from 11% and 67% (Moyers, Houck, Rice,
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Longabaugh, & Miller, 2016; Miller and Moyers, 2015; Miller, Taylor, & West, 1980).
Also, our findings are contrary to the body of evidence that clinician interpersonal skill
and ability to create an alliance with the client is correlated with larger differences in
outcomes than the differences produced by the individual treatment modality (Miller and
Moyers, 2015; Messer & Wamphold, 2002).
One explanation for our null findings could be that global score measurement is
particularly unreliable and less rigorous as opposed to a tally score. Recent research has
highlighted concerns with Likert-scales in social sciences. One limitation is that
respondents are artificially required to pick a stance (even if they lack an opinion),
because these scales have no neutral point (Brown, 2006; Croasmun & Ostrom, 2011).
Further, in Likert-scales with odd numbers, such as the MITI, the middle option acts as
“neutral” and is more frequently chosen in moments of indecision, which increases
response bias (Croasmun & Ostrom, 2011; Fernandez & Randall, 1991). Another
possible explanation for the lack of therapist effects in this sample is that interventionists
were crossed with treatment conditions. Because the therapists were evaluated highly on
their global ratings, which encompass common factors such as empathy and partnership,
an interventionists interpersonal skill may have potentially bled through into the
screening and assessment conditions. This hypothesis is further supported by the fact that
in the parent study all treatment conditions had improvements in drinking and drug use at
3 months after baseline. Given these shortcomings, a more concrete form of measuring
clinician global scores may be warranted in future studies.
Summary and Implications
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Overall, the conclusion from this secondary analysis is clear: MI was not effective
in reducing substance use with clients present for urgent medical care. These data raise
the hypothesis that MI might not be applicable in this hectic environment. It may be that
individuals presenting for a pressing physical health issue are not as ambivalent about
their substance use. This may be particularly true as they were non-treatment seeking for
substance use issues. In support of this inference, four other trials researching the efficacy
of MI in this real-world environment found low effect sizes ranging from .02-.16
(Vasilaki, Hoiser, & Cox, 2006; Gentilello et al., 1999; Longabaugh et al., 1996; Monti et
al., 1999). Given the minimal impact of this treatment urgent care, future research should
focus on methods that can more easily translate to patient care.
One final deduction from these data is that monitoring and reporting treatment
quality are essential to efficacy research. As this study shows, in order to be sure (or in
this case not sure) that the intervention given was the one intended it is essential to
measure and report fidelity. Measuring competency is time-consuming, tedious, and
expensive but vital. A final recommendation is for RCTs to assess integrity continuously,
not just as an afterthought. Our secondary analysis was unable to paint a clearer picture of
how MI quality is associated with client outcome, but has highlighted the importance of
trying to clear up these muddy waters by placing a higher value on treatment fidelity.
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Appendix A. Tables
Table 1. Descriptions of MITI 3.0 Codes
MITI Code
Globals
Evocation

Brief Description

Conveys an understanding that motivation and ability for change reside
within the client.

Collaboration

Encourages power sharing with client and allows client’s ideas to
influence the session.

Autonomy/Support

Supports and fosters client perception of choice.

Direction

Maintains focus on a specific target goal.

Empathy

Understands or makes an effort to grasp the client's perspective and
experience.

Behavior Counts
Giving Information

Gives information, educates, provides feedback, or expresses a
professional opinion without persuading, advising, or warning.

MI Adherent

Category that includes behaviors consistent with MI spirit including:
asking permission before giving advice, saying something positive or
complimentary of a client, emphasizing the client’s autonomy, and
statements of compassion or sympathy.

MI Non-adherent

Category that includes behaviors inconsistent with MI spirit including:
advise without permission, confronting, or giving orders or commands.

Open Question

A question with a wide range of possible answers.

Closed Question

A question that can be answered with a “yes” or “no” response or with a
restricted range.

Simple Reflection

Reflects a client's statement with little or no added meaning or
emphasis.
Reflects a client's statement with added meaning or emphasis.

Complex Reflection
Summary measures
Global Spirit Rating

(Evocation + Collaboration + Autonomy/Support + Direction +
Empathy)/ 5

Percent Complex
Reflection

Complex Reflections/(Simple Reflections + Complex Reflections)

Percent Open
Questions

Open Questions/(Closed Questions + Open Questions)
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Reflection to Question
Ratio

(Simple Reflections + Complex Reflections)/ (Closed Questions + Open
Questions)

Percent MI Adherent
MI Adherent/ (MI Adherent + MI Non-Adherent)
Notes. Table created from the manual by Moyers, Martin, Manuel, Miller, and Ernst (2007).
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Table 2. MITI Proficiency Standards
MI Summary Score Thresholds

Beginner

Full Strength

Global Clinician Ratings

Mean of 3.5

Mean of 4

Reflection to Question Ratio (R:Q)

1

2

Percent Open Questions (%OC)

50%

70%

Percent Complex Reflections (%CR)

40%

50%

Percent MI-Adherent (%MIA)

90%

100%
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Table 3. Means and Standard Deviations of MITI Scores
MITI Scores

Beginner MI (N=159)

Advanced MI (N=27)

M

SD

M

SD

Evocation

4.52

0.63

4.62

0.50

Collaboration

4.57

0.58

4.62

0.50

Autonomy Support

4.46

0.55

4.46

0.51

Direction

4.83

0.43

4.88

0.33

Empathy

4.66

0.51

4.65

0.49

Giving Information

1.94

2.17

1.08

1.85

MI-Adherent

4.69

3.22

4.31

2.96

MI-Not adherent

0.02

0.13

0.00

0.00

Closed Question

4.73

3.00

2.58

1.90

Open Question

9.29

4.76

8.19

4.40

Simple Reflection

8.10

4.90

8.88

5.84

Complex Reflection

15.69

6.21

18.73

8.29

Average of the Global Scores 4.60

0.44

4.65

0.35

R:Q

2.02

1.25

3.25

2.17

%OC

66.78

12.01

79.19

10.13

%CR

66.80

13.19

68.50

10.86

%MIA

99.84

1.20

100.00

0.00

Global Scores

Behavior Counts

Summary Scores
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Table 4. Percentage of Sessions that met each of the MITI 3.0 Proficiency Standards
Clinician Summary Score

Percentage of Sessions that met the

Thresholds

Standard

Global Clinician Ratings

Beginner MI

Full Strength MI

93.0%

81.96%

Reflection to Question Ratio (R:Q) 74.2%

25.3%

Percent Open Questions (%OC)

58.5%

22.9%

Percent Complex Reflections

91.2%

78.4%

Percent MI-Adherent (%MIA)

90.6%

85.8%

Met all 5 Threshold Scores

41.5%

07.3%

(%CR)

31
Table 5. Obliquely rotated component loadings for the MITI 3.0
Factor 2: Technical Factor 3: Evocation

Component

Factor 1: MI Spirit

Collaboration

.872

Autonomy Support

.860

Empathy

.821

Evocation

.806

.321

Direction

.534

.329

MI-Adherent

.469

.416

Closed Question

.751

Simple Reflection

.743

Giving Information

.480

Complex Reflection

.392

.467
.433

MI-Non-adherent

.667

Open Question
Eigenvalues

4.075

2.576

1.219

Percentage of total

34.044

21.470

10.155

7

6

3

variance
Number of MITI
measures
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Appendix B: Figures:
Figure 1. Percentage of the Sample that met MI Proficiency Standards.

41%	
  
52%	
  

7%	
  

Beginning	
  MI	
  

Advanced	
  MI	
  

Did	
  not	
  meet	
  the	
  bar	
  for	
  MI	
  

33
References
Acosta, M., Haller, D. L., & Ingersoll, A. K. (2010). The Science of Motivational
Interviewing. Handbook of Motivation and Change: A Practical Guide for
Clinicians, 237.
Aharonovich, E., Amrhein, P. C., Bisaga, A., Nunes, E. V., & Hasin, D. (2008).
Cognition, Commitment Language, and Behavioral Change Among Cocaine
Dependent Patients. Psychology of Addictive Behaviors  : Journal of the Society of
Psychologists in Addictive Behaviors, 22(4), 557–562.
https://doi.org/10.1037/a0012971
Amrhein, P. C., Miller, W. R., Yahne, C. E., Palmer, M., & Fulcher, L. (2003). Client
commitment language during motivational interviewing predicts drug use
outcomes. Journal of Consulting and Clinical Psychology, 71(5), 862–878.
https://doi.org/10.1037/0022-006X.71.5.862
Armstrong, M. J., Mottershead, T. A., Ronksley, P. E., Sigal, R. J., Campbell, T. S., &
Hemmelgarn, B. R. (2011). Motivational interviewing to improve weight loss in
overweight and/or obese patients: a systematic review and meta-‐‑analysis of
randomized controlled trials. Obesity Reviews, 12(9), 709-723. doi:
10.1111/j.1467-789X.2011.00892.x
Baer, J. S., Rosengren, D. B., Dunn, C. W., Wells, E. A., Ogle, R. L., & Hartzler, B.
(2004). An evaluation of workshop training in motivational interviewing for
addiction and mental health clinicians. Drug and Alcohol Dependence, 73(1), 99–
106.

34
Baer, J. S., Beadnell, B., Garrett, S. B., Hartzler, B., Wells, E. A., & Peterson, P. L.
(2008). Adolescent change language within a brief motivational intervention and
substance use outcomes. Psychology of Addictive Behaviors: Journal of the
Society of Psychologists in Addictive Behaviors, 22(4), 570–575.
https://doi.org/10.1037/a0013022
Beidas, R., Kendall, P.C. (2010). Training therapists in evidence-based practice: A
critical review of studies from a systems-contextual perspective. Clinical
Psychology: Science and Practice. 17(1):1–30. doi: 10.1111/j.14682850.2009.01187.x
Boardman, T., Catley, D., Grobe, J. E., Little, T. D., & Ahluwalia, J. S. (2006). Using
motivational interviewing with smokers: do therapist behaviors relate to
engagement and therapeutic alliance? Journal of Substance Abuse Treatment,
31(4), 329–339. https://doi.org/10.1016/j.jsat.2006.05.006
Brown, J.D. (2000). What issues affect Likert-scale questionnaire formats? JALT Testing
& Evaluation SIG, 4, 27-30.
Burnam, M.A., Hepner, K.A., & Miranda, J. (2009). Future research on psychotherapy
practice in usual care. Administration and Policy in Mental Health and Mental
Health Services Research. 36:1–5. doi: 10.1007/s10488-009-0254-7.
Burke, B. L., Arkowitz, H., & Menchola, M. (2003). The efficacy of motivational
interviewing: a meta-analysis of controlled clinical trials. Journal of consulting
and clinical psychology, 71(5), 843.
Bush, K., Kivlahan, D. R., McDonell, M. B., Fihn, S. D., & Bradley, K. A. (1998). The
AUDIT Alcohol Consumption Questions (AUDIT-C): An Effective Brief

35
Screening Test for Problem Drinking. Archives of Internal Medicine, 158(16),
1789–1795. https://doi.org/10.1001/archinte.158.16.1789
Cicchetti, D. V., & Sparrow, S. A. (1981). Developing criteria for establishing interrater
reliability of specific items: applications to assessment of adaptive
behavior. American Journal of Mental Deficiency
COMBINE Study Research Group. (2003). Testing combined pharmacotherapies and
behavioral interventions in alcohol dependence: rationale and methods.
Alcoholism, clinical and experimental research, 27(7), 1107.
Croasmun, J. T., & Ostrom, L. (2011). Using Likert-Type Scales in the Social Sciences.
Journal of Adult Education, 40(1), 19–22.
D’Amico, E. J., Houck, J. M., Hunter, S. B., Miles, J. N., Osilla, K. C., & Ewing, B. A.
(2015). Group motivational interviewing for adolescents: change talk and alcohol
and marijuana outcomes. Journal of consulting and clinical psychology, 83(1), 68.
Damschroder, L.J., Hagedorn, H.J. (2011). A guiding framework and approach for
implementation research in substance use disorders treatment. Psychology of
Addictive Behaviors. 25(2):194–205. doi: 10.1037/a0022284.
Donovan, J. J., & Radosevich, D. J. (1999). A meta-analytic review of the distribution of
practice effect: Now you see it, now you don’t. Journal of Applied Psychology,
84(5), 795–805. https://doi.org/10.1037/0021-9010.84.5.795
Fernandes, M., & Randall, D. (1991). The social desirability response bias in ethics
research. Journal of Business Ethics, 10 (11), 805-807.
Forsberg, L., Källmén, H., Hermansson, U., Berman, A. H., & Helgason, Á. R. (2007).
Coding Counsellor Behaviour in Motivational Interviewing Sessions: Inter-‐‑Rater

36
Reliability for the Swedish Motivational Interviewing Treatment Integrity Code
(MITI). Cognitive Behaviour Therapy, 36(3), 162-169.
Gentilello, L. M., Rivara, F. P., Donovan, D. M., Jurkovich, G. J., Daranciang, E., Dunn,
C. W., … Ries, R. R. (1999). Alcohol interventions in a trauma center as a means
of reducing the risk of injury recurrence. Annals of Surgery, 230(4), 473-480;
discussion 480-483.
Glynn, L. H., & Moyers, T. B. (2010). Chasing change talk: the clinician’s role in
evoking client language about change. Journal of Substance Abuse Treatment,
39(1), 65–70. https://doi.org/10.1016/j.jsat.2010.03.012
Hallgren, K. A. (2012). Computing inter-rater reliability for observational data: an
overview and tutorial. Tutorials in quantitative methods for psychology, 8(1), 23.
Handmaker, N. S., Miller, W. R., & Manicke, M. (1999). Findings of a pilot study of
motivational interviewing with pregnant drinkers. Journal of studies on alcohol,
60(2), 285-287.
Harding, R., Dockrell, M. J. D., Dockrell, J., & Corrigan, N. (2001). Motivational
interviewing for HIV risk reduction among gay men in commercial and public sex
settings. AIDS care, 13(4), 493-501.
Head, M.L., Holman, L., Lanfear, R., Kahn, A.T., Jennions, M.D. (2015) The Extent and
Consequences of P-Hacking in Science. PLoS Biology 13(3): e1002106.
doi:10.1371/journal.pbio.1002106
Hettema, J., Steele, J., & Miller, W. R. (2005). Motivational interviewing. Annual.
Review of Clinical Psychology, 1, 91-111. doi:
10.1146/annurev.clinpsy.1.102803.143833

37
Hodgins, D. C., Ching, L. E., & McEwen, J. (2009). Strength of commitment language in
motivational interviewing and gambling outcomes. Psychology of Addictive
Behaviors: Journal of the Society of Psychologists in Addictive Behaviors, 23(1),
122–130. https://doi.org/10.1037/a0013010
Houck, J.M., & Moyers, T.B. (2008). What you do matters: Therapist influence on client
behavior during motivational interviewing sessions. Poster session presented at
the International Addiction Summit, Melbourne, Australia.
Humeniuk, R., Ali, R., Babor, T.F., et al. (2008) Validation of the Alcohol, Smoking and
Substance Involvement Screening Test (ASSIST). Addiction. 103(6): 1039-1047.
Kadden, R., Carbonari, J., Litt, M., Tonigan, S., & Zweben, A. (1998). Matching
alcoholism treatments to client heterogeneity: Project MATCH three-year
drinking outcomes. Alcohol Clinical Experimental Research, 22, 1300-1311.
Longabaugh, R., Woolard, R. E., Nirenberg, T. D., Minugh, A. P., Becker, B., Clifford,
P. R., … Gogineni, A. (2001). Evaluating the effects of a brief motivational
intervention for injured drinkers in the emergency department. Journal of Studies
on Alcohol, 62(6), 806–816. https://doi.org/10.15288/jsa.2001.62.806
Lundahl, B., Moleni, T., Burke, B. L., Butters, R., Tollefson, D., Butler, C., & Rollnick,
S. (2013). Motivational interviewing in medical care settings: a systematic review
and meta-analysis of randomized controlled trials. Patient education and
counseling, 93(2), 157-168. doi:
Madson, M. B., & Campbell, T. C. (2006). Measures of fidelity in motivational
enhancement: A systematic review. Journal of substance abuse treatment, 31(1),
67-73. doi:10.1016/j.jsat.2006.03.010.

38
Madson, M. B., Campbell, T. C., Barrett, D. E., Brondino, M. J., & Melchert, T. P.
(2005). Development of the motivational interviewing supervision and training
scale. Psychology of Addictive Behaviors, 19(3), 303.
McLeod, B. D., Southam-Gerow, M., & Weisz, J. R. (2009). Conceptual and
methodological issues in treatment integrity measurement. School Psychology
Review, 38(4), 541.
McMurran, M. (2009). Motivational interviewing with offenders: A systematic review.
Legal and Criminological Psychology, 14(1), 83-100.
Messer, S. B., & Wampold, B. E. (2002). Let’s Face Facts: Common Factors Are More
Potent Than Specific Therapy Ingredients. Clinical Psychology: Science and
Practice, 9(1), 21–25. https://doi.org/10.1093/clipsy.9.1.21
Miller, W. R. (1995). Motivational enhancement therapy manual: A clinical research
guide for therapists treating individuals with alcohol abuse and dependence (Vol.
2). DIANE Publishing.
Miller, W. R. (2001). When is it motivational interviewing? Addiction, 96, 1770– 1771.
Miller, W. R., & Moyers, T. B. (2015). The forest and the trees: relational and specific
factors in addiction treatment. Addiction, 110(3), 401-413.
Miller, W. R., & Rose, G. S. (2009). Toward a theory of motivational
interviewing. American Psychologist, 64(6), 527.
Miller, W. R., & Rollnick, S. (2012). Motivational interviewing: Helping people change.
Guilford press.
Miller, W. R., & Sanchez, V. C. (1994). Motivating young adults for treatment and
lifestyle change. University of Notre Dame Press.

39
Miller, W. R., Taylor, C. A., & West, J. c. (1980). Focused versus broad-spectrum
behavior therapy for problem drinkers. Journal of Consulting and Clinical
Psychology, 48(5), 590–601.
Miller, W. R., Yahne, C. E., Moyers, T. B., Martinez, J., & Pirritano, M. (2004). A
randomized trial of methods to help clinicians learn motivational interviewing.
Journal of Consulting and Clinical Psychology, 72(6), 1050–1062.
https://doi.org/10.1037/0022-006X.72.6.1050
Monti, P. M., & Rohsenow, D. J. (1999). Coping-skills training and cue-exposure therapy
in the treatment of alcoholism. Alcohol Research & Health: The Journal of the
National Institute on Alcohol Abuse and Alcoholism, 23(2), 107–115.
Moyers, T. B., Houck, J., Rice, S. L., Longabaugh, R., & Miller, W. R. (2016). Therapist
empathy, combined behavioral intervention, and alcohol outcomes in the
COMBINE research project. Journal of Consulting and Clinical Psychology,
84(3), 221–229. https://doi.org/10.1037/ccp0000074
Moyers, T. B., Martin, T., Manuel, J. K., Hendrickson, S. M., & Miller, W. R. (2005).
Assessing competence in the use of motivational interviewing. Journal of
substance abuse treatment, 28(1), 19-26.
Moyers, T., Martin, T., Catley, D., Harris, K. J., & Ahluwalia, J. S. (2003). Assessing the
integrity of motivational interviewing interventions: Reliability of the
motivational interviewing skills code. Behavioural and Cognitive Psychotherapy,
31(02), 177-184.

40
Moyers, T. B., Rowell, L. N., Manuel, J. K., Ernst, D., & Houck, J. M. (2016). The
Motivational Interviewing Treatment Integrity Code (MITI 4): Rationale,
preliminary reliability and validity. Journal of Substance Abuse Treatment.
Moyers, T. B., Manuel, J. K., Wilson, P. G., Hendrickson, S. M. L., Talcott, W., &
Durand, P. (2008). A randomized trial investigating training in motivational
interviewing for behavioral health providers. Behavioural and Cognitive
Psychotherapy, 36(2), 149–162. https://doi.org/10.1017/S1352465807004055
Parsons, J. T., Rosof, E., Punzalan, J. C., & Maria, L. D. (2005). Integration of
motivational interviewing and cognitive behavioral therapy to improve HIV
medication adherence and reduce substance use among HIV-positive men and
women: results of a pilot project. AIDS Patient Care & STDs, 19(1), 31-39.
Perepletchikova, F. (2011). On the topic of treatment integrity. Clinical Psychology:
Science and Practice, 18(2), 148-153. doi:10.1111/j.1468-2850.2011.01246.x.
Perepletchikova, F., Kazdin, A.E. (2005) Treatment integrity and therapeutic change:
Issues and research recommendations. Clinical Psychology: Science and Practice.
12:365–383. doi: 10.1093/clipsy/bpi045.
Prochaska, J. O., & Norcross, J. C. (2007). Systems of psychotherapy: A transtheoretical
approach. South Melbourne, Australia: Thompson Brooks/Cole.
Rogers, C. R. (1951). Client-centered Therapy: Its Current Practice, Implications, and
Theory, with Chapters. Houghton Mifflin.
Rollnick, S., & Miller, W. R. (1995). What is motivational interviewing? Behavioural
and Cognitive Psychotherapy, 23(04), 325-334.

41
Rubak, S., Sandbæk, A., Lauritzen, T., & Christensen, B. (2005). Motivational
interviewing: a systematic review and meta-analysis. British Journal of General
Practice, 55(513), 305-312. doi:
Skinner, H. A. (1982). The drug abuse screening test. Addictive Behaviors, 7(4), 363–
371.
Sobell, L.C., Sobell, M.B. (1992). Timeline follow-back: a technique for assessing selfreported alcohol consumption. In: Litten RA, Allen JP, eds. Measuring Alcohol
Consumption: Psychosocial and Biological Methods. Totowa, NJ: Humana Press.
Southam-‐‑Gerow, M. A., & McLeod, B. D. (2013). Advances in applying treatment
integrity research for dissemination and implementation science: Introduction to
special issue. Clinical Psychology: Science and Practice, 20(1), 1-13. doi:
10.1111/j.1468-2850.2006.00001.x.
Tollison, S. J., Lee, C. M., Neighbors, C., Neil, T. A., Olson, N. D., & Larimer, M. E.
(2008). Questions and reflections: the use of motivational interviewing
microskills in a peer-led brief alcohol intervention for college students. Behavior
Therapy, 39(2), 183–194. https://doi.org/10.1016/j.beth.2007.07.001
Vader, A. M., Walters, S. T., Prabhu, G. C., Houck, J. M., & Field, C. A. (2010). The
language of motivational interviewing and feedback: counselor language, client
language, and client drinking outcomes. Psychology of Addictive Behaviors:
Journal of the Society of Psychologists in Addictive Behaviors, 24(2), 190–197.
https://doi.org/10.1037/a0018749

42
VanBuskirk, K. A., & Wetherell, J. L. (2014). Motivational interviewing with primary
care populations: a systematic review and meta-analysis. Journal of behavioral
medicine, 37(4), 768-780.
Vasilaki, E. I., Hosier, S. G., & Cox, W. M. (2006). The efficacy of motivational
interviewing as a brief intervention for excessive drinking: a meta-analytic
review. Alcohol and Alcoholism, 41(3), 328-335.
Webb, C.A., DeRubeis, R.J., Barber, J.P. (2010). Therapist adherence/competence and
treatment outcome: A meta-analytic review. Journal of Consulting and Clinical
Psychology. 78(2):200–211. doi: 10.1037/a0018912.
Witkiewitz, K., Falk, D. E., Kranzler, H. R., Litten, R. Z., Hallgren, K. A., O'malley, S.
S., & Anton, R. F. (2014). Methods to analyze treatment effects in the presence of
missing data for a continuous heavy drinking outcome measure when participants
drop out from treatment in alcohol clinical trials. Alcoholism: clinical and
experimental research, 38(11), 2826-2834.

